John C. Reed, M.D., Ph.D.
Executive Vice President, Innovative Medicine Research and Development, Johnson & Johnson
In the news
J&J completes $1 billion cash acquisition of Firefly Bio
Johnson & Johnson completed its acquisition of Firefly Bio for $1 billion in cash.
M&A